Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP1404216.RAVGWxPxlXJ7s_vUL0Ge6ftEOk5Qv9kMtq3AzNJzmUjt4130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP1404216.RAVGWxPxlXJ7s_vUL0Ge6ftEOk5Qv9kMtq3AzNJzmUjt4130_assertion type Assertion NP1404216.RAVGWxPxlXJ7s_vUL0Ge6ftEOk5Qv9kMtq3AzNJzmUjt4130_head.
- NP1404216.RAVGWxPxlXJ7s_vUL0Ge6ftEOk5Qv9kMtq3AzNJzmUjt4130_assertion description "[Finally, this study indicates that serous cystadenocarcinomas may be suitable tumours for MAGE-1 peptide immunotherapy.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1404216.RAVGWxPxlXJ7s_vUL0Ge6ftEOk5Qv9kMtq3AzNJzmUjt4130_provenance.
- NP1404216.RAVGWxPxlXJ7s_vUL0Ge6ftEOk5Qv9kMtq3AzNJzmUjt4130_assertion evidence source_evidence_literature NP1404216.RAVGWxPxlXJ7s_vUL0Ge6ftEOk5Qv9kMtq3AzNJzmUjt4130_provenance.
- NP1404216.RAVGWxPxlXJ7s_vUL0Ge6ftEOk5Qv9kMtq3AzNJzmUjt4130_assertion SIO_000772 9743307 NP1404216.RAVGWxPxlXJ7s_vUL0Ge6ftEOk5Qv9kMtq3AzNJzmUjt4130_provenance.
- NP1404216.RAVGWxPxlXJ7s_vUL0Ge6ftEOk5Qv9kMtq3AzNJzmUjt4130_assertion wasDerivedFrom befree-2016 NP1404216.RAVGWxPxlXJ7s_vUL0Ge6ftEOk5Qv9kMtq3AzNJzmUjt4130_provenance.
- NP1404216.RAVGWxPxlXJ7s_vUL0Ge6ftEOk5Qv9kMtq3AzNJzmUjt4130_assertion wasGeneratedBy ECO_0000203 NP1404216.RAVGWxPxlXJ7s_vUL0Ge6ftEOk5Qv9kMtq3AzNJzmUjt4130_provenance.